These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14688491)

  • 41. Hypertension and the renin-angiotensin system in the congenital hydronephrosis rat with non-obstructive pelviureteric junction abnormalities.
    Tauchi K; Kanehara H
    Exp Nephrol; 1996; 4(1):60-4. PubMed ID: 8788602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of the patient with resistant hypertension.
    Tarazi RC
    Hosp Pract (Off Ed); 1981 Jan; 16(1):49-57. PubMed ID: 6786972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and clinical investigations in patients with low-renin hypertension.
    Mackenzie IS; Brown MJ
    Clin Exp Nephrol; 2009 Feb; 13(1):1-8. PubMed ID: 18704622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemodialysis-associated hypertension; pathophysiology and therapy].
    Suzuki H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():220-4. PubMed ID: 15250299
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
    Nast HP; Philipp T
    Fortschr Med; 1974 Apr; 92(11):447-51. PubMed ID: 4362672
    [No Abstract]   [Full Text] [Related]  

  • 46. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renin inhibitors in the management of hypertension.
    Oparil S
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):706-7. PubMed ID: 17786072
    [No Abstract]   [Full Text] [Related]  

  • 49. Short-term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus.
    Chen AX; Jerums G; Baqar S; Lambert E; Somarajah G; Thomas G; O'Callaghan C; MacIsaac RJ; Ekinci EI
    Clin Sci (Lond); 2015 Sep; 129(5):415-22. PubMed ID: 25849646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients.
    Aoki A; Ogawa T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Nitta K
    Heart Vessels; 2010 May; 25(3):195-202. PubMed ID: 20512446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
    van Paassen P; de Zeeuw D; de Jong PE
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):39-45. PubMed ID: 7564363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atherosclerosis, arterial stiffness and antihypertensive drug therapy.
    Safar ME; Smulyan H
    Adv Cardiol; 2007; 44():331-351. PubMed ID: 17075219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension.
    Laragh J
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):837-54. PubMed ID: 11587148
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma renin activity testing to guide triple antirenin system drug therapy in a patient with difficult-to-treat hypertension.
    Shah S; Coakley C; Hough A; Parra D
    Ann Pharmacother; 2013 Nov; 47(11):1562-8. PubMed ID: 24285769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated Renin and Aldosterone Levels in a Young Woman With Hypertension.
    Kfoury B; Cohen JB
    Am J Kidney Dis; 2020 Jun; 75(6):A11-A13. PubMed ID: 32446415
    [No Abstract]   [Full Text] [Related]  

  • 56. Calcium antagonists as first-choice therapy for low-renin essential hypertension.
    Bühler FR
    Kidney Int; 1989 Aug; 36(2):295-305. PubMed ID: 2674520
    [No Abstract]   [Full Text] [Related]  

  • 57. Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension.
    Laragh JH
    Am J Hypertens; 2001 Dec; 14(12):1173-7. PubMed ID: 11775122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vascular wall renin-angiotensin system as a target of therapeutic interventions].
    Karpov IuA
    Kardiologiia; 2003; 43(5):82-6. PubMed ID: 12942932
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma renin activity and systemic arterial hypertension.
    Kirkendall WM; Overturf M
    Mod Concepts Cardiovasc Dis; 1973 Oct; 42(10):47-52. PubMed ID: 4784809
    [No Abstract]   [Full Text] [Related]  

  • 60. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
    Lantelme P; Lo M; Sassard J
    Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.